- Home
- ASAN vs CPRX Comparison
ASAN vs CPRX Comparison
Compare ASAN & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASAN
- CPRX
- Stock Information
- Founded
- ASAN 2008
- CPRX 2002
- Country
- ASAN United States
- CPRX United States
- Employees
- ASAN N/A
- CPRX N/A
- Industry
- ASAN Retail: Computer Software & Peripheral Equipment
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- ASAN Technology
- CPRX Health Care
- Exchange
- ASAN Nasdaq
- CPRX Nasdaq
- Market Cap
- ASAN 3.3B
- CPRX 2.8B
- IPO Year
- ASAN 2020
- CPRX 2006
- Fundamental
- Price
- ASAN $14.84
- CPRX $22.52
- Analyst Decision
- ASAN Hold
- CPRX Strong Buy
- Analyst Count
- ASAN 18
- CPRX 7
- Target Price
- ASAN $16.12
- CPRX $32.29
- AVG Volume (30 Days)
- ASAN 3.1M
- CPRX 1.7M
- Earning Date
- ASAN 05-29-2025
- CPRX 05-07-2025
- Dividend Yield
- ASAN N/A
- CPRX N/A
- EPS Growth
- ASAN N/A
- CPRX 107.94
- EPS
- ASAN N/A
- CPRX 1.31
- Revenue
- ASAN $723,876,000.00
- CPRX $491,734,000.00
- Revenue This Year
- ASAN $10.64
- CPRX $15.17
- Revenue Next Year
- ASAN $10.03
- CPRX $9.61
- P/E Ratio
- ASAN N/A
- CPRX $17.19
- Revenue Growth
- ASAN 10.94
- CPRX 23.49
- 52 Week Low
- ASAN $11.05
- CPRX $14.47
- 52 Week High
- ASAN $27.77
- CPRX $26.16
- Technical
- Relative Strength Index (RSI)
- ASAN 45.17
- CPRX 48.15
- Support Level
- ASAN $14.71
- CPRX $21.93
- Resistance Level
- ASAN $16.22
- CPRX $23.27
- Average True Range (ATR)
- ASAN 1.12
- CPRX 1.27
- MACD
- ASAN 0.21
- CPRX -0.14
- Stochastic Oscillator
- ASAN 53.80
- CPRX 50.60
About ASAN Asana Inc.
Asana is a provider of collaborative work management software delivered via a cloud-based SaaS model. The firm's solution offers scalable, dynamic tools to improve the efficiency of project and process management across countless use cases, including marketing programs, managing IT approvals, and performance management. Asana's offering supports workflow management across teams, provides real time visibility into projects, and reporting and automation capabilities. The firm generates revenue via software subscriptions on a per seat basis.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).